BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21213589)

  • 1. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity.
    Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T
    New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.
    Fu TM; Freed DC; Horton MS; Fan J; Citron MP; Joyce JG; Garsky VM; Casimiro DR; Zhao Q; Shiver JW; Liang X
    Virology; 2009 Mar; 385(1):218-26. PubMed ID: 19070878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.
    Wang Y; Zhou L; Shi H; Xu H; Yao H; Xi XG; Toyoda T; Wang X; Wang T
    Biochem Biophys Res Commun; 2009 Jul; 385(1):118-22. PubMed ID: 19410554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus.
    Muto NA; Yoshida R; Suzuki T; Kobayashi S; Ozaki H; Fujikura D; Manzoor R; Muramatsu M; Takada A; Kimura T; Sawa H
    Jpn J Vet Res; 2012 Aug; 60(2-3):71-83. PubMed ID: 23094582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
    Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
    Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes.
    Poungpair O; Chaicumpa W; Kulkeaw K; Maneewatch S; Thueng-in K; Srimanote P; Tongtawe P; Songserm T; Lekcharoensuk P; Tapchaisri P
    J Virol Methods; 2009 Jul; 159(1):105-11. PubMed ID: 19442853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells.
    Melik-Nubarov NS; Suzdaltseva YuG ; Priss EL; Slepnev VI; Kabanov AV; Zhirnov OP; Sveshnikov PG; Severin ES
    Biochem Mol Biol Int; 1993 Apr; 29(5):939-47. PubMed ID: 8508145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
    Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
    Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanized anti-M2 scFv shows protective in vitro activity against influenza.
    Gabbard J; Velappan N; Di Niro R; Schmidt J; Jones CA; Tompkins SM; Bradbury AR
    Protein Eng Des Sel; 2009 Mar; 22(3):189-98. PubMed ID: 19054791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of strictinin on influenza virus replication.
    Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T
    Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.
    Wang R; Song A; Levin J; Dennis D; Zhang NJ; Yoshida H; Koriazova L; Madura L; Shapiro L; Matsumoto A; Yoshida H; Mikayama T; Kubo RT; Sarawar S; Cheroutre H; Kato S
    Antiviral Res; 2008 Nov; 80(2):168-77. PubMed ID: 18598723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
    Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling influenza virus replication by inhibiting its proton channel.
    Pinto LH; Lamb RA
    Mol Biosyst; 2007 Jan; 3(1):18-23. PubMed ID: 17216051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
    Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
    Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.
    Watanabe T; Watanabe S; Ito H; Kida H; Kawaoka Y
    J Virol; 2001 Jun; 75(12):5656-62. PubMed ID: 11356973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W; Zou P; Chen YH
    Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oligomeric state of the active BM2 ion channel protein of influenza B virus.
    Balannik V; Lamb RA; Pinto LH
    J Biol Chem; 2008 Feb; 283(8):4895-904. PubMed ID: 18073201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
    Roberts PC; Lamb RA; Compans RW
    Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza virus proton channels.
    Pinto LH; Lamb RA
    Photochem Photobiol Sci; 2006 Jun; 5(6):629-32. PubMed ID: 16761092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.